Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC
Public ClinicalTrials.gov record NCT00602030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study With a Lead in Phase of Erlotinib With or Without SNDX-275 in Patients With NSCLC After Failure In Up to Two Prior Chemotherapeutic Regimens for Advanced Disease
Study identification
- NCT ID
- NCT00602030
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Syndax Pharmaceuticals
- Industry
- Enrollment
- 141 participants
Conditions and interventions
Interventions
- Entinostat Drug
- Placebo Drug
- Erlotinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2008
- Primary completion
- Feb 3, 2010
- Completion
- Jan 31, 2012
- Last update posted
- Aug 21, 2022
2008 – 2012
United States locations
- U.S. sites
- 30
- U.S. states
- 13
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HOPE (Hematology Oncology Physicians & Extenders) | Tucson | Arizona | — | — |
| Rocky Mountain Cancer Center | Denver | Colorado | — | — |
| Advanced Medical Specialties | Miami | Florida | — | — |
| Ocala Oncology Center | Ocala | Florida | — | — |
| Cancer Centers of Florida | Ocoee | Florida | — | — |
| Hematology Oncology Associates of Illinois | Chicago | Illinois | — | — |
| Central Indiana Cancer Centers | Indianapolis | Indiana | — | — |
| Kansas City Cancer Centers | Overland Park | Kansas | — | — |
| Alliance Hematology Oncology | Westminster | Maryland | — | — |
| St Joseph Oncology | Saint Joseph | Missouri | — | — |
| The Center for Cancer Care & Research | St Louis | Missouri | — | — |
| Mahonig Valley Hematology Oncology Associates | Boardman | Ohio | — | — |
| Dayton Oncology & Hematology | Kettering | Ohio | — | — |
| Oncology Associates of Oregon | Eugene | Oregon | — | — |
| Texas Oncology | Amarillo | Texas | — | — |
| Texas Oncology | Austin | Texas | — | — |
| Texas Oncology | Bedford | Texas | — | — |
| Texas Oncology, Sammons Cancer Center | Dallas | Texas | — | — |
| Texas Oncology | Dallas | Texas | — | — |
| Texas Oncology | Fort Worth | Texas | — | — |
| Texas Oncology | Garland | Texas | — | — |
| Texas Oncology | Longview | Texas | — | — |
| Texas Oncology | Midland | Texas | — | — |
| Texas Oncology | Odessa | Texas | — | — |
| Texas Oncology | Tyler | Texas | — | — |
| Fairfax Northern Virginia Hematology-Oncology | Fairfax | Virginia | — | — |
| Virginia Oncology Associates | Norfolk | Virginia | — | — |
| Highline Medical Oncology | Burien | Washington | — | — |
| Cancer Care Northwest | Spokane | Washington | — | — |
| Yakima Valley Memorial Hospital/North Star Lodge | Yakima | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00602030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00602030 live on ClinicalTrials.gov.